Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Acacia Research Registration Statement Declared Effective.


Business Editors

NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif.--(BUSINESS WIRE)--Nov. 8, 2002

Acacia acacia (əkā`shə), any plant of the large leguminous genus Acacia, often thorny shrubs and trees of the family Leguminosae (pulse family).  Research Corporation (Nasdaq:ACRI) announced today that its Registration Statement on Form S-4 has been declared effective by the Securities and Exchange Commission. The Registration Statement relates to the Company's Special Meeting of Stockholders, to be held on December 11, 2002, at which stockholders will vote on several proposals.

At the Special Meeting, stockholders of record on November 1, 2002 will vote on the recapitalization Recapitalization

Restructuring a company's debt and equity mixture often with the aim of making a company's capital structure more stable.

Notes:
Companies often want to diversify their debt-to-equity ratio to improve liquidity.
 of Acacia Research to divide its common stock into two new classes -- "Acacia Research -- CombiMatrix" stock, that is intended to reflect the performance of its subsidiary CombiMatrix Corporation, and "Acacia Research -- Acacia Technologies
''Acacia Technologies was also the name of division within Computer Associates that effectively closed down in 2002 when its assets were sold to SSA Global Technologies.
" stock, that is intended to reflect the performance of Acacia Research's media technology businesses. The "Acacia Research -- CombiMatrix" stock and the "Acacia Research -- Acacia Technologies" stock are both classes of common stock of Acacia Research and are not stock issued by the respective groups.

If the proposal is approved, Acacia Research stockholders would receive shares of both of the new classes of stock in exchange for the shares they now hold.

Stockholders will also vote on a merger agreement pursuant to which Acacia Research would acquire the shares of CombiMatrix that Acacia Research does not already own. The proposed acquisition would be accomplished through a merger in which the stockholders of CombiMatrix other than Acacia Research would receive shares of the new "Acacia Research -- CombiMatrix" stock, in exchange for their existing shares. Stockholders will also vote on two related proposals to approve new stock incentive plans for each business group.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities covered by the Registration Statement or determined if the proxy statement Proxy Statement

A document containing the information that a company is required by the SEC to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual stockholder meeting.
 and prospectus which are part of the Registration Statement is truthful or complete. Any representation to the contrary is a criminal offense.

About Acacia Research Corporation

Acacia Research develops, licenses and provides products for the life science and media technology sectors. Acacia licenses its V-chip technology to television manufacturers and owns pioneering technology for digital streaming and video-on-demand. Acacia Research's CombiMatrix subsidiary is developing a bio-chip technology for the life science market. Acacia Research's Web site is located at www.acaciaresearch.com.

About CombiMatrix

CombiMatrix is developing a platform technology that has a wide range of applications, from DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 synthesis/diagnostics to immunochemical im·mu·no·chem·is·try  
n.
The chemistry of immunologic phenomena, as of antigen-antibody reactions.



im
 detection. The platform allows the company to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The company is designing its products principally to be responsive to the needs of pharmaceutical, biotechnology, and academic researchers in analyzing raw genomic data in the discovery and development of pharmaceutical products. CombiMatrix's Web site is located at www.combimatrix.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement under the Private Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 

Reform Act of 1995

This news release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q

See 10-Q.
, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

Where You Can Find Additional Information

In connection with the proposed recapitalization and merger, Acacia Research has filed with the SEC a proxy statement/prospectus and other relevant materials that contain important information about the merger, the recapitalization and the stock incentive plans. The proxy statement/prospectus will be mailed to the stockholders of Acacia Research and CombiMatrix. Investors and stockholders of Acacia Research and CombiMatrix are urged to read the proxy statement/prospectus when it is available and the other relevant materials because they contain important information about Acacia Research, CombiMatrix, the merger, the recapitalization and the stock incentive plans. The proxy statement/prospectus and other relevant materials and any other documents filed by Acacia Research with the SEC may be obtained free of charge at the SEC's Web site at www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by Acacia Research by directing a request to: Acacia Research Corporation, 500 Newport Center Newport Center is a business, shopping, and entertainment district located on a high bluff overlooking Newport Harbor in Newport Beach, California. It was created in the early 1960s as part of William Pereira's master plan for the Irvine Ranch.  Drive, Newport Beach, CA 92660, Attn: Investor Relations Investor relations

The process by which the corporation communicates with its investors.
. Investors and security holders are urged to read the proxy statement/prospectus and the other relevant materials before making any voting or investment decision with respect to the merger, the recapitalization or the stock incentive plans.

Acacia Research, CombiMatrix and their respective executive officers and directors may be deemed to be participants in the solicitation of proxies from the stockholders of Acacia Research in favor of the merger, the recapitalization and the stock incentive plans. Investors and security holders may obtain more detailed information regarding the direct and indirect interests of Acacia Research, CombiMatrix and their respective executive officers in the recapitalization, merger and stock incentive plans by reading the proxy statement/prospectus regarding the transactions.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 8, 2002
Words:921
Previous Article:ADVISORY/Update: HP to Showcase Innovation in Action at Fall Comdex 2002.
Next Article:NRG Energy Confirms Debt Acceleration.



Related Articles
Acacia Research makes announcement.
Acacia Research's Majority-Owned Subsidiary, CombiMatrix Corp., Files for Initial Public Offering.
Acacia Research Declares a Ten Percent Stock Dividend.
Acacia Research Reports Record Fourth Quarter and Fiscal Year 2001 Financial Results.
Acacia Research Announces Plan to Create Separate Nasdaq Listed Public Shares for Its CombiMatrix and Acacia Technologies Businesses.
CombiMatrix Group to Receive $13.6 Million from Acacia Research Registered Direct Offering.
Acacia Technologies Group to Receive $19.6 Million from Acacia Research Registered Direct Offering.
CombiMatrix to Receive $2.9 Million from Registered Direct Offering.
Acacia Research Corporation Receives Notice from Nasdaq Staff Regarding Trading Price of CBMX Stock.
CombiMatrix to Receive $5 Million from Registered Direct Offering.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles